Centerline Biomedical Introduces IOPS Visionary™, Its Next-Generation 3D Endovascular Navigation Platform

New 510(k)-cleared platform integrates real-time electromagnetic device tracking, advanced 3D visualization, and intuitive physician controls.

CLEVELAND, OH, UNITED STATES, November 10, 2026 /EINPresswire.com/ -- Centerline Biomedical, Inc. (“Centerline”), a medical technology company advancing image-guided endovascular navigation, today announced the U.S. launch of the IOPS Visionary™ System, the next generation of its innovative IOPS^® (Intra-Operative Positioning System) technology. Designed to advance how physicians visualize, interact with, and navigate within complex vascular anatomy, IOPS Visionary introduces a substantially modernized platform that brings together real-time electromagnetic navigation, patient-specific 3D vascular mapping, interactive imaging integration, and an enhanced physician experience.

Endovascular interventions are performed within complex three-dimensional anatomy, yet conventional fluoroscopic imaging typically presents anatomical and device information through two-dimensional projections. IOPS provides an additional navigational perspective by displaying the real-time position and orientation of compatible sensor-equipped interventional devices within a patient-specific 3D vascular map.
From 2D Projection to 3D Orientation

At the foundation of IOPS is electromagnetic navigation technology that enables real-time tracking of compatible sensor-equipped guidewires and catheters. Unlike fluoroscopic imaging, the electromagnetic tracking technology itself does not emit ionizing radiation. IOPS is intended for use as an adjunct to fluoroscopy, providing physicians with complementary spatial information during endovascular navigation.

Building on this technology, IOPS Visionary introduces a new generation of capabilities designed to make advanced navigation more intuitive, interactive, and integrated into the procedural environment.

Among its principal advancements are:

• Enhanced 3D visualization: Advanced software and visualization capabilities that display tracked-device position and orientation within patient-specific vascular anatomy.
• Spintegration™ intraoperative 3D updates: Incorporation of cone-beam CT imaging acquired during the procedure, allowing newly deployed devices and updated anatomical information to be displayed within the 3D navigation environment.
• Live Fluoroscopic Overlay: Integration of live fluoroscopic information with the rendered IOPS vascular map, bringing current procedural imaging into the navigation environment.
• Direct tableside physician interaction: Intuitive controls that provide physicians with greater accessibility to and interaction with navigational information during the procedure.
• Modernized system architecture: Expanded display capabilities, updated software, and a contemporary mobile system design supporting a more integrated physician experience.

Together, these capabilities extend IOPS beyond navigation within a preoperative vascular model by enabling additional imaging information to be incorporated as the intervention progresses.

Advanced Navigation. Designed Around the Intervention.

“IOPS Visionary represents an important advancement in how physicians visualize and navigate complex vascular anatomy,” said Michael Costanza, MD, Chief, Division of Vascular Surgery and Endovascular Services, Upstate University Hospital, Syracuse, NY. “By providing real-time device positioning within a patient-specific 3D environment, together with updated intraoperative imaging information, the system offers a valuable new dimension of spatial orientation during endovascular procedures. As we continue to evaluate the clinical applications of this technology, one particularly promising area is its potential to reduce fluoroscopy utilization and associated radiation exposure during lengthy, complex interventions.”

“The introduction of IOPS Visionary marks a significant milestone for Centerline and the continued evolution of our IOPS technology,” noted Vikash Goel, the company’s Founder and Chief Technology Officer. “Our mission has always been about providing doctors with a fundamentally different way to navigate in minimally invasive procedures, and to understand where their devices are in the body. IOPS Visionary builds on that foundation by elevating the technology platform to give physicians more control, more information, and a more intuitive experience with IOPS. Moreover, the IOPS Visionary platform will serve as the basis for continued innovation as we work to bring about the future of image guidance in endovascular interventions.”

The IOPS Visionary System has received U.S. Food and Drug Administration 510(k) clearance. The platform supports real-time positioning and navigation of compatible IOPS sensor-equipped devices within peripheral, aortic, and aortic side-branch vasculature as an adjunct to fluoroscopy, consistent with its cleared indications for use.

Centerline will introduce IOPS Visionary to the vascular community at the 2026 VEITHsymposium, November 17–21, in New York City, providing an opportunity for physicians and industry stakeholders to learn more about the platform and its advanced navigation capabilities.

About Centerline Biomedical

Founded in 2015 and headquartered in Cleveland, Ohio, Centerline Biomedical, Inc. develops image-guided navigation technology for endovascular and transcatheter procedures. The company’s commercially available IOPS^® (Intra-Operative Positioning System) technology platform is designed to enhance visualization and provide three-dimensional navigation to support physicians during procedures.

Designed to advance how physicians visualize, interact with, and navigate within complex vascular anatomy, the IOPS Visionary system introduces a substantially modernized platform that brings together real-time electromagnetic navigation, patient-specific 3D vascular mapping, interactive imaging integration, and an enhanced physician experience.

Centerline continues to invest in the development of its IOPS platform to further enhance its capabilities and expand image-guidance applications across transcatheter procedures.

Centerline Biomedical, the Centerline logo, IOPS, and IOPS Visionary trademarks or registered trademarks of Centerline Biomedical. Any unauthorized use is expressly prohibited.

Merle Adelman
Adelman Associates
+1 978-761-4512
merle.adelman@adelmanassociates.com
Visit us on social media:
LinkedIn